[18F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results
暂无分享,去创建一个
M. Forsting | O. Kraff | P. Heusch | L. Umutlu | K. Beiderwellen | T. Lauenstein | P. Buderath | J. Grueneisen | B. Aktas | Verena Ruhlmann
[1] K. Sugimura,et al. Fusion of PET and MRI for staging of uterine cervical cancer: comparison with contrast-enhanced (18)F-FDG PET/CT and pelvic MRI. , 2014, Clinical imaging.
[2] Felix Nensa,et al. Depiction and characterization of liver lesions in whole body [¹⁸F]-FDG PET/MRI. , 2013, European journal of radiology.
[3] K. Sugimura,et al. Value of fusion of PET and MRI in the detection of intra-pelvic recurrence of gynecological tumor: comparison with 18F-FDG contrast-enhanced PET/CT and pelvic MRI , 2013, Annals of Nuclear Medicine.
[4] M. Forsting,et al. Diffusion-weighted imaging as part of hybrid PET/MRI protocols for whole-body cancer staging: does it benefit lesion detection? , 2013, European journal of radiology.
[5] A. Ba-Ssalamah,et al. Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation , 2013, European Radiology.
[6] Kathleen R. Cho,et al. Cervical cancer. , 2013, Journal of the National Comprehensive Cancer Network : JNCCN.
[7] C. Claussen,et al. Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study. , 2012, Radiology.
[8] I. Steffen,et al. Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours , 2012, European Radiology.
[9] G. Psychogios,et al. Carcinoma of unknown primary in the head and neck: Comparison between positron emission tomography (PET) and PET/CT , 2011, Head & neck.
[10] Masatoshi Hori,et al. 18F-FDG PET/MRI fusion in characterizing pancreatic tumors: comparison to PET/CT , 2011, International Journal of Clinical Oncology.
[11] Kathleen R. Cho,et al. Cervical cancer. , 2013, Journal of the National Comprehensive Cancer Network : JNCCN.
[12] G. V. von Schulthess,et al. Value of Retrospective Fusion of PET and MR Images in Detection of Hepatic Metastases: Comparison with 18F-FDG PET/CT and Gd-EOB-DTPA–Enhanced MRI , 2010, Journal of Nuclear Medicine.
[13] Nassir Navab,et al. Tissue Classification as a Potential Approach for Attenuation Correction in Whole-Body PET/MRI: Evaluation with PET/CT Data , 2009, Journal of Nuclear Medicine.
[14] A. Giuliano,et al. Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity , 2009, Cancer Causes & Control.
[15] P. Grigsby,et al. Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer. , 2009, Gynecologic Oncology.
[16] Byung Kwan Park,et al. Detection of Recurrent Ovarian Cancer at MRI: Comparison With Integrated PET/CT , 2007, Journal of computer assisted tomography.
[17] V. Bettinardi,et al. Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[18] R. Felix,et al. Impact of FDG-PET/MRI Image Fusion on the Detection of Pancreatic Cancer , 2007, Pancreatology.
[19] T. Beyer,et al. PET Versus PET/CT Dual-Modality Imaging in Evaluation of Lung Cancer. , 2006, PET clinics.
[20] T. Torizuka,et al. Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer , 2005, International Journal of Clinical Oncology.
[21] Thomas Beyer,et al. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] Thomas Beyer,et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Patrick M M Bossuyt,et al. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. , 2003, Gynecologic oncology.